XML 31 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Jun. 30, 2020
Current assets:    
Cash and cash equivalents $ 1,613,100,000 $ 1,908,500,000
Accounts receivable, net of allowance for doubtful accounts of $89.1 and $92.5, respectively 2,489,100,000 2,441,300,000
Other current assets 762,900,000 506,200,000
Total current assets before funds held for clients 4,865,100,000 4,856,000,000.0
Funds held for clients 29,950,300,000 26,708,100,000
Total current assets 34,815,400,000 31,564,100,000
Long-term receivables, net of allowance for doubtful accounts of $0.6 and $0.5, respectively 16,100,000 18,600,000
Property, plant and equipment, net 701,500,000 703,900,000
Operating lease right-of-use asset 479,000,000.0 493,700,000
Deferred contract costs 2,397,900,000 2,401,600,000
Other assets 438,000,000.0 458,400,000
Goodwill 2,326,300,000 2,309,400,000
Intangible assets, net 1,215,900,000 1,215,800,000
Total assets 42,390,100,000 39,165,500,000
Current liabilities:    
Accounts payable 111,200,000 102,000,000.0
Accrued expenses and other current liabilities 1,900,200,000 1,980,700,000
Accrued payroll and payroll-related expenses 494,700,000 557,000,000.0
Dividends payable 387,100,000 387,300,000
Short-term deferred revenues 205,000,000.0 212,500,000
Obligations under reverse repurchase agreements [1] 0 13,600,000
Short-term debt 0 1,001,800,000
Income taxes payable 133,000,000.0 40,100,000
Total current liabilities before client funds obligations 3,231,200,000 4,295,000,000.0
Client funds obligations 29,098,400,000 25,831,600,000
Total current liabilities 32,329,600,000 30,126,600,000
Long-term debt 1,993,900,000 1,002,800,000
Operating lease liabilities 330,400,000 344,400,000
Other liabilities 813,900,000 837,000,000.0
Deferred income taxes 743,000,000.0 731,900,000
Long-term deferred revenues 370,400,000 370,600,000
Total liabilities 36,581,200,000 33,413,300,000
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none 0 0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at September 30, 2020 and June 30, 2020; outstanding, 429.3 and 429.9 shares at September 30, 2020 and June 30, 2020, respectively 63,900,000 63,900,000
Capital in excess of par value 1,348,400,000 1,333,800,000
Retained earnings 18,644,700,000 18,436,300,000
Treasury stock - at cost: 209.4 and 208.9 shares at September 30, 2020 and June 30, 2020, respectively (14,264,000,000.0) (14,067,000,000.0)
Accumulated other comprehensive income (loss) 15,900,000 (14,800,000)
Total stockholders’ equity 5,808,900,000 5,752,200,000
Total liabilities and stockholders’ equity $ 42,390,100,000 $ 39,165,500,000
[1] (A) As of June 30, 2020, $13.6 million of long-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements (see Note 9).